Structural GenomiX, Inc. And Cystic Fibrosis Foundation Solve Crystal Structure Of Integral Disease-Causing Region Of Cystic Fibrosis Protein To Reveal Critical And Previously Undiscovered Change
10/19/2005 5:12:20 PM
More...
|
Structural GenomiX, Inc. Achieves All Year-One Milestones In Eli Lilly and Company (LLY) Collaboration
10/19/2005 5:11:34 PM
More...
|
Structural GenomiX, Inc. Acquires Anti-Cancer Agent From Shire BioChem, Inc.
10/19/2005 5:11:21 PM
More...
|
Structural GenomiX, Inc. Appoints Neill Giese, Ph.D. As Senior Vice President Of Drug Development
10/19/2005 5:11:00 PM
More...
|
Structural GenomiX, Inc. Forms Drug Discovery Collaboration With Serono (SRA) Utilizing Proprietary SGX FAST(TM) Lead Generation; Up To $68 Million
10/19/2005 5:10:33 PM
More...
|
RoboDesign International, Inc. To Provide Custom High-Throughput Crystallization Solution For Structural GenomiX, Inc.
10/19/2005 5:10:32 PM
More...
|
FDA Grants Structural GenomiX, Inc. Orphan Drug Designation For Troxatyl(TM); SGX To Present Troxatyl(TM) Clinical Data At American Society of Clinical Oncology
10/19/2005 5:10:15 PM
More...
|
Roche (RHHBY) And Structural GenomiX, Inc. Enter New Anti-Viral Drug Discovery Partnership
10/19/2005 5:10:14 PM
More...
|
Structural GenomiX, Inc. Reports Interim Clinical Data Of Troxatyl(TM) (Troxacitabine) Anti-Cancer Drug For Acute Myelogenous Leukemia At 2005 American Society of Clinical Oncology Annual Meeting
10/19/2005 5:10:03 PM
More...
|
Structural GenomiX, Inc. Expands Relationship With Eli Lilly and Company (LLY)
10/19/2005 5:09:40 PM
More...
|
|